Status:
UNKNOWN
The ZWOlle Transmural Integrated Care for CArdiovaScular Risk Management Study
Lead Sponsor:
UMC Utrecht
Collaborating Sponsors:
Isala
Medrie Health Care Group, Zwolle
Conditions:
Cardiovascular Diseases
Hypercholesterolemia
Eligibility:
All Genders
40-80 years
Brief Summary
Cardiovascular disease (CVD) contributes importantly to mortality and morbidity. Prevention of CVD by lifestyle change and medication is important and needs full attention. In the Netherlands an inte...
Eligibility Criteria
Inclusion
- Inclusion criteria for patients with CVD:
- Patients with a history of atherosclerotic CVD defined as documented angina pectoris, myocardial infarction, chronic ischemic heart disease, coronary sclerosis, transient ischaemic attack (TIA), cerebral infarction, intermittent claudication or aneurysm of the abdominal aorta
- The CV risk of the patient is managed in primary care, not in the hospital or outpatient clinic by a medical specialist
- Age between 40 and 80 years
- Inclusion criteria for high risk patients:
- Use of blood pressure lowering or lipid lowering drugs
- A 10 -years CV risk \> 10%, based on the Dutch guideline for CVRM and i) either 1 strongly cardiovascular risk enhancing factor or 2 mildly cardiovascular risk enhancing factors (see table 6) or ii) \> 1 CV risk factor (current smoking, SBP\>140 mmHg, LDL\>2.5 mmol/L, TC/HDL-ratio \> 8, chronic renal impairment (age \< 65 years: eGFR \< 60 ml/min/1,73 m2; age ≥ 65 years: eGFR \< 45 ml/min/1,73 m2, and/or (micro)albuminuria).
- A 10-year CV risk of \>20% and \> 1 CV risk factor (current smoking, SBP\>140 mmHg, LDL\>2.5 mmol/L, TC/HDL-ratio \> 8, chronic renal impairment (age \< 65 years: eGFR \< 60 ml/min/1,73 m2; age ≥ 65 years: eGFR \< 45 ml/min/1,73 m2, and/or (micro)albuminuria).
- The CV risk of the patient is managed in primary care, not in the hospital or outpatient clinic by a medical specialist
- Age between 40 and 80 years
- Exclusion criteria for all patients:
- Diabetes mellitus, as these patients are already included in a disease management program for diabetes mellitus
- Limited life expectancy, as assessed by the GP
- Cognitive impairment, as assessed by the GP
- No Dutch language proficiency
- Staying abroad for longer than three months during the duration of the study.
- The CV risk of the patient is managed in the hospital or outpatient clinic by a medical specialist
Exclusion
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2018
Estimated Enrollment :
740 Patients enrolled
Trial Details
Trial ID
NCT03428061
Start Date
September 1 2017
End Date
March 31 2018
Last Update
February 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
General Practices
Zwolle, Overijssel, Netherlands